These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 19691215

  • 1. Expression of decoy receptor 3 in liver tissue microarrays.
    Chen G, Luo D.
    Natl Med J India; 2008; 21(6):275-8. PubMed ID: 19691215
    [Abstract] [Full Text] [Related]

  • 2. [Overexpression and genomic amplification of decoy receptor 3 in hepatocellular carcinoma and significance thereof].
    Shen HW, Wu YL, Peng SY.
    Zhonghua Yi Xue Za Zhi; 2003 May 10; 83(9):744-7. PubMed ID: 12899749
    [Abstract] [Full Text] [Related]

  • 3. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].
    Chen G, Luo DZ, Wang Y, Liao ZL, Zhang MY.
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb 10; 36(2):113-7. PubMed ID: 17493386
    [Abstract] [Full Text] [Related]

  • 4. Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development.
    Chen C, Zhang C, Zhuang G, Luo H, Su J, Yin P, Wang J.
    Cancer Invest; 2008 Dec 10; 26(10):965-74. PubMed ID: 19093253
    [Abstract] [Full Text] [Related]

  • 5. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
    Liu Y, Chen X, Peng S, Fang H, Wu Y, Peng C, Shi L, Bai M, Xu B, Wang J, Deng G.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 25; 82(22):1553-6. PubMed ID: 12609066
    [Abstract] [Full Text] [Related]

  • 6. Wilms' tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis.
    Sera T, Hiasa Y, Mashiba T, Tokumoto Y, Hirooka M, Konishi I, Matsuura B, Michitaka K, Udaka K, Onji M.
    Eur J Cancer; 2008 Mar 25; 44(4):600-8. PubMed ID: 18255279
    [Abstract] [Full Text] [Related]

  • 7. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma.
    Chan KL, Guan XY, Ng IO.
    Hum Pathol; 2004 Nov 25; 35(11):1324-31. PubMed ID: 15668888
    [Abstract] [Full Text] [Related]

  • 8. Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome.
    Chang PM, Chen PM, Hsieh SL, Tzeng CH, Liu JH, Chiou TJ, Wang WS, Yen CC, Gau JP, Yang MH.
    Int J Oncol; 2008 Sep 25; 33(3):549-54. PubMed ID: 18695885
    [Abstract] [Full Text] [Related]

  • 9. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].
    Zhou Q, Liang LJ, Peng BG, Zhen YY.
    Ai Zheng; 2006 Nov 25; 25(11):1433-8. PubMed ID: 17094916
    [Abstract] [Full Text] [Related]

  • 10. [Determination of expression of eight p53-related genes in hepatocellular carcinoma with tissue microarrays].
    Zhu MH, Ni CR, Zhu Z, Li FM, Zhang SM.
    Ai Zheng; 2003 Jul 25; 22(7):680-5. PubMed ID: 12866955
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
    Yuan RH, Jeng YM, Chen HL, Lai PL, Pan HW, Hsieh FJ, Lin CY, Lee PH, Hsu HC.
    J Pathol; 2006 Aug 25; 209(4):549-58. PubMed ID: 16739096
    [Abstract] [Full Text] [Related]

  • 13. Angiopoietins and Tie-2 expression in angiogenesis and proliferation of human hepatocellular carcinoma.
    Mitsuhashi N, Shimizu H, Ohtsuka M, Wakabayashi Y, Ito H, Kimura F, Yoshidome H, Kato A, Nukui Y, Miyazaki M.
    Hepatology; 2003 May 25; 37(5):1105-13. PubMed ID: 12717391
    [Abstract] [Full Text] [Related]

  • 14. The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma.
    Ikeguchi M, Iwamoto A, Taniguchi K, Katano K, Hirooka Y.
    J Exp Clin Cancer Res; 2005 Sep 25; 24(3):415-21. PubMed ID: 16270528
    [Abstract] [Full Text] [Related]

  • 15. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C, Yang B, Gao YT, Wang YJ, Nie FH, Yuan Q, Zhang CL, Du Z.
    Zhonghua Zhong Liu Za Zhi; 2008 Nov 25; 30(11):831-6. PubMed ID: 19173828
    [Abstract] [Full Text] [Related]

  • 16. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
    Okamoto M, Utsunomiya T, Wakiyama S, Hashimoto M, Fukuzawa K, Ezaki T, Hanai T, Inoue H, Mori M.
    Ann Surg Oncol; 2006 Jul 25; 13(7):947-54. PubMed ID: 16788756
    [Abstract] [Full Text] [Related]

  • 17. Significance of decoy receptor 3 in sera of hepatocellular carcinoma patients.
    Yang M, Chen G, Dang Y, Luo D.
    Ups J Med Sci; 2010 Nov 25; 115(4):232-7. PubMed ID: 20977315
    [Abstract] [Full Text] [Related]

  • 18. Novel markers of cell kinetics to evaluate progression from cirrhosis to hepatocellular carcinoma.
    Quaglia A, McStay M, Stoeber K, Loddo M, Caplin M, Fanshawe T, Williams G, Dhillon A.
    Liver Int; 2006 May 25; 26(4):424-32. PubMed ID: 16629645
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
    Pan HW, Ou YH, Peng SY, Liu SH, Lai PL, Lee PH, Sheu JC, Chen CL, Hsu HC.
    Cancer; 2003 Jul 01; 98(1):119-27. PubMed ID: 12833464
    [Abstract] [Full Text] [Related]

  • 20. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G, Romano M, Calabrò A, Pedone PV, de Sio I, Persico M, Budillon G, Bruni CB, Riccio A, Zarrilli R.
    Hepatology; 1996 Jun 01; 23(6):1304-12. PubMed ID: 8675143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.